tm
Seeing Is Believing
tm
Seeing Is Believing
Eiger Biopharmaceuticals's activity chart (see below) currently has 23 price targets and 18 ratings on display.
Analysts average stock forecasts to be materialized ratio is 38.1% with an average time for these price targets to be met of 427.21 days.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 29-Aug-2023.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Jun-2019
$26
3 years 1 months 2 days ago
(29-Aug-2023)
1/3 (33.33%)
$-224.2 (-89.61%)
694
Buy
$3
$0.95 (46.34%)
$3
3 years 3 months ago
(30-Jun-2023)
2/2 (100%)
$2.3 (328.57%)
294
Buy Since 09-May-2018
$150
$147.95 (7217.07%)
3 years 3 months 1 days ago
(30-Jun-2023)
0/3 (0%)
$128.88 (610.23%)
Buy Since 19-Dec-2018
$44
4 years 24 days ago
(07-Sep-2022)
2/2 (100%)
$-118 (-72.84%)
1215
Buy Since 16-May-2018
$29
$26.95 (1314.63%)
$690
4 years 6 months 14 days ago
(17-Mar-2022)
1/3 (33.33%)
$-210.4 (-87.89%)
370
What is EIGR (Eiger Biopharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on EIGR (Eiger Biopharmaceuticals)?
Which analyst has the most public recommendations on EIGR (Eiger Biopharmaceuticals)?
Which analyst is the currently most bullish on EIGR (Eiger Biopharmaceuticals)?
Which analyst is the currently most reserved on EIGR (Eiger Biopharmaceuticals)?
